Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (8): 793-798.doi: 10.3736/jcim20080805
• Original Clinical Research • Previous Articles Next Articles
Shao-ying Lou, Yi Liu, Yu-ying Ma, Hai-ying Chen, Wei-hua Chen, Jian Ying, Yan-ming He, Wen-jian Wang(
)
CLC Number:
| [1] |
Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Guidelines for diagnosis and treatment of non-alcoholic fatty liver disease[J]. Gan Zang, 2006,11(1):68-70
doi: 10.3969/j.issn.1008-1704.2006.01.032 |
|
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南[J]. 肝脏, 2006,11(1):68-70
doi: 10.3969/j.issn.1008-1704.2006.01.032 |
|
| [2] |
Delgado JS . Evolving trends in nonalcoholic fatty liver disease[J]. Eur J Intern Med, 2008,19(2):75-82
doi: 10.1016/j.ejim.2007.02.034 pmid: 18249301 |
| [3] | Zheng XY. Guiding principles for clinical research on new drugs of traditional Chinese medicine[M]. Beijing: Chinese Medical Science and Technology Press,2002: 148 |
| 郑筱萸 . 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社,2002: 148 | |
| [4] |
Leclercq IA, Da Silva Morais A, Schroyen B , et al.Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences[J]. J Hepatol, 2007,47(1):142-156
doi: 10.1016/j.jhep.2007.04.002 pmid: 17512085 |
| [5] | Wang WJ . Foundation and application of aggregation syndrome theory in traditional Chinese medicine[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(2):111-114 |
| 王文健 . 聚证学说的建立和应用[J]. 中西医结合学报, 2007,5(2):111-114 | |
| [6] |
Kong W, Wei J, Abidi P , et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004,10(12):1344-1351
doi: 10.1038/nm1135 |
| [7] |
Lee YS, Kim WS, Kim KH , et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J]. Diabetes, 2006,55(8):2256-2264
doi: 10.2337/db06-0006 |
| [8] |
Wang SH, Wang WJ, Wang XF , et al. Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(10):926-928
doi: 10.3321/j.issn:1003-5370.2004.10.017 |
|
王树海, 王文健, 汪雪峰 , 等. 黄芪多糖和小檗碱对3T3-L1脂肪细胞糖代谢及细胞分化的影响[J]. 中国中西医结合杂志, 2004,24(10):926-928
doi: 10.3321/j.issn:1003-5370.2004.10.017 |
|
| [9] | He CY, Wang WJ, Li F , et al. Clinical research of Yiqi Sanju Formula in treating central obese men at high risk of metabolic syndrome[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(3):263-267 |
| 何春燕, 王文健, 李玢 , 等. 益气散聚方治疗代谢综合征肥胖高危人群的临床研究[J]. 中西医结合学报, 2007,5(3):263-267 | |
| [10] |
Adams LA, Angulo P, Lindor KD . Nonalcoholic fatty liver disease[J]. CMAJ, 2005,172(7):899-905
doi: 10.1503/cmaj.1050122 pmid: 16186572 |
| [11] | Rodríguez-Leal GA, Morán S, Gallardo I , et al. Assessment of high sensitivity C-reactive protein(hs-CRP) as a marker of liver inflammation in patients with metabolic syndrome[J]. Rev Gastroenterol Mex, 2006,71(1):39-45 |
| [12] |
Zhou H, Xu B, Xu NN , et al. The comparison of diagnostic value between CT and ultrasonic examination in low-grade fatty liver[J]. Shou Du Yi Ke Da Xue Xue Bao, 2006,27(4):541-543
doi: 10.3969/j.issn.1006-7795.2006.04.035 |
|
周海, 徐冰, 徐霓霓 , 等. CT和超声检查对轻度脂肪肝诊断价值的比较[J]. 首都医科大学学报, 2006,27(4):541-543
doi: 10.3969/j.issn.1006-7795.2006.04.035 |